“Specialty Cost”

12 result(s)
Cost Management
Specialty Spend: Balancing Affordability and Member Experience
Payor strategies for specialty drug spend must strike a balance between affordability and member experience. More
Commentary
Specialty
Better Managing Psoriasis Across the Duration of Therapy
Innovative strategies can help payors manage pharmacy costs and care for plan members with psoriasis. More
Briefing
Specialty
Eliminate Specialty Waste with Indication, Weight-Based Dosing
Utilizing indication and weight-based dosing helps proactively and prospectively prevent inappropriate dose escalation and ultimately avoid wasteful spend More
Briefing
A smiling pharmacist talks on the phone
Specialty
Intelligent Medication Monitoring for Targeted Specialty Interventions
Monitoring efficacy and outcomes of high cost specialty medications can help lower costs for payors More
Briefing
Eliminate Specialty Waste by Preventing Excess Accumulation | Payor Solutions | CVS Health
Specialty
Eliminate Specialty Waste by Preventing Excess Accumulation
Supply Management Optimization helps prevent waste, lowers plan costs More
Briefing
Specialty
Enduring Specialty Cost Savings with Clinically Sound Therapy Decisions
Clinically rigorous, accredited UM, and EHR connectivity helps ensure durable denials that deliver true, lasting savings. More
Briefing
Treatment Options Expanding for Atopic Dermatitis
Drug Pipeline
Treatment Options Expanding for Atopic Dermatitis
A range of new treatment options for AD are expected to come to market in the next couple years. Effective management strategies can help payors manage cost. More
Briefing
Addressing Rising Specialty Costs
Specialty
Addressing Rising Specialty Costs
Hear Prem Shah, Executive Vice President, CVS Health, addresses solutions for rising specialty drug costs. More
Video
Specialty
IBD Treatment Options on the Rise
Our proven strategies including step therapy, Specialty Guideline Management, and cross-benefit management can help clients better manage costs for the growing number of IBD... More
Feature
Drug Pipeline
Number of HAE Treatments Increasing
Over the past dozen years, several new treatments have come to market with the first oral preventive expected to be approved in December. Targeted management to help balance... More
Feature